Company Filing History:
Years Active: 2012
Title: The Innovations of Michael J Caulfield
Introduction
Michael J Caulfield is a notable inventor based in Ft. Washington, PA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines. His work focuses on creating innovative solutions to combat infectious diseases.
Latest Patents
One of his most significant patents is the 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition. This invention provides a multivalent immunogenic composition that includes 15 distinct polysaccharide-protein conjugates. Each conjugate is derived from a different serotype, including 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, or 33F, and is conjugated to a carrier protein, preferably CRM. The immunogenic composition is formulated as a vaccine with an aluminum-based adjuvant, offering broad coverage against pneumococcal disease, especially in infants and young children.
Career Highlights
Michael J Caulfield is associated with Merck Sharp & Dohme Corporation, where he has contributed to various research and development projects. His expertise in vaccine development has positioned him as a key figure in the fight against pneumococcal diseases.
Collaborations
Some of his notable coworkers include Patrick L Ahl and Jeffrey T Blue, who have collaborated with him on various projects related to vaccine development.
Conclusion
Michael J Caulfield's innovative work in vaccine development has made a significant impact on public health. His contributions continue to advance the field of immunology and provide essential solutions for preventing infectious diseases.